IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 29 October 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00982-07v1
76/1/97    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saville, S. P.
Right arrow Articles by Lopez-Ribot, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saville, S. P.
Right arrow Articles by Lopez-Ribot, J. L.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00982-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Use of a Genetically Engineered Strain to Evaluate the Pathogenic Potential of Yeast and Filamentous Forms during Candida albicans Systemic Infection in Immunodeficient Mice

Stephen P. Saville, Anna L. Lazzell, Ashok K. Chaturvedi, Carlos Monteagudo, and Jose L. Lopez-Ribot*

Dept. of Biology, The University of Texas at San Antonio, San Antonio, Texas and Departmento de Patología, Universidad de Valencia, Facultad de Medicina y Odontología, Valencia, Spain

* To whom correspondence should be addressed. Email: jose.lopezribot{at}utsa.edu.


   Abstract

The pathogenesis of C. albicans systemic infection is complex and results from the balance between its intrinsic virulence attributes and the host immune responses. Morphogenetic transitions between yeast and filamentous forms are considered one of the main virulence attributes in C. albicans. We have examined the pathogenesis of a genetically engineered C. albicans strain, in which morphogenetic conversions can be externally manipulated, in immunodeficient mice; these included B-cell deficient, nude (T-cell-deficient), SCID (lacking both functional T and B cells), and DBA/2N (C5 deficient with impaired neutrophil activity) mice. We also tested mice severely immunosuppressed by cyclophosphamide/cortisone acetate treatment. Mice with specific immune defects were able to survive an infection by yeast cells, but not filamentous forms. However, yeast cells displayed a pathogenic effect leading to lethality in the severely the immunosuppressed mice.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.